Walleye Capital LLC Regeneron Pharmaceuticals, Inc. Put Options Transaction History

Walleye Capital LLC

14 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$883.2 - $1071.19 $4.06 Million - $4.93 Million	-4,600 Reduced 23.23%	15,200 $16 Million
Q1 2024 May 15, 2024	BUY	$902.69 - $993.35 $9.57 Million - $10.5 Million	10,600 Added 115.22%	19,800 $19.1 Million
Q4 2023 Feb 14, 2024	SELL	$775.18 - $881.7 $2.71 Million - $3.09 Million	-3,500 Reduced 27.56%	9,200 $8.08 Million
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $8.1 Million - $9.88 Million	11,700 Added 1170.0%	12,700 $10.5 Million
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $630,027 - $747,315	-900 Reduced 47.37%	1,000 $718,000
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $1.09 Million - $1.32 Million	1,600 Added 533.33%	1,900 $1.56 Million
Q4 2022 Feb 14, 2023	SELL	$705.89 - $766.39 $776,479 - $843,029	-1,100 Reduced 78.57%	300 $216,000
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $803,558 - $1.01 Million	1,400 New	1,400 $964,000
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $197,328 - $257,567	-400 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$336.18 - $494.43 $2.19 Million - $3.21 Million	-6,500 Reduced 94.2%	400 $195,000
Q4 2019 Feb 14, 2020	SELL	$274.13 - $376.51 $1.29 Million - $1.77 Million	-4,700 Reduced 40.52%	6,900 $2.59 Million
Q3 2019 Nov 14, 2019	BUY	$273.46 - $318.39 $2.84 Million - $3.31 Million	10,400 Added 866.67%	11,600 $3.22 Million
Q2 2019 Aug 14, 2019	SELL	$299.6 - $414.82 $329,560 - $456,302	-1,100 Reduced 47.83%	1,200 $376,000
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $855,784 - $1.01 Million	2,300 New	2,300 $944,000

1,463

84.5M

907K

1.3M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $112B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.